YRC Worldwide Reports First Quarter 2018 Results
May 03, 2018 12:45 pm UTC| Business
OVERLAND PARK, Kan., May 03, 2018 -- YRC Worldwide Inc. (NASDAQ:YRCW) reported consolidated operating revenue for first quarter 2018 of $1.215 billion and a consolidated operating loss of $4.3 million, which included a...
Aequus Receives Positive FDA Regulatory Guidance for Anti-Nausea Patch
May 03, 2018 12:45 pm UTC| Business
Key Highlights FDA has confirmed that an abbreviated 505(b)(2) regulatory pathway would be appropriate for the submission of AQS1303, Aequus’ long-acting anti-nausea patch for nausea and vomiting associated with...
Arterial Stents Market to touch Valuation of US$17.8 Bn by 2025 End, Says TMR
May 03, 2018 12:42 pm UTC| Business
Albany, NY, May 03, 2018 -- The global arterial stents is projected to expand at a promising CAGR of 9.5% from 2017 to 2025 and by the end of this period, the market is expected to reach a worth of US$17.8 bn. In 2016,...
May 03, 2018 12:40 pm UTC| Business
MIAMI, May 03, 2018 -- Veru Inc. (NASDAQ:VERU), a urology and oncology biopharmaceutical company, today announced that data from a pre-clinical study of VERU-111, a novel oral alpha and beta tubulin inhibitor showing...
May 03, 2018 12:38 pm UTC| Business
Albany, New York, May 03, 2018 -- Although regional players are many and currently occupy over a quarter of the global volume share for wood activated carbon, this market is primarily consolidated. The top three players...
ISBG Outlines Strategy for Long Term, Balanced Growth
May 03, 2018 12:36 pm UTC| Business
LAS VEGAS, NV, May 03, 2018 -- International Spirits and Beverage Group Inc., (a Nevada Corporation) (OTCPK:ISBG) is preparing to expand operations and hopes to fulfill aggressive 2018 plans following successful...
May 03, 2018 12:31 pm UTC| Business
HOUSTON, May 03, 2018 -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on...